PCSK9

experts-address-barriers-to-pcsk9-therapies-in-ascvd-treatment

Experts Address Barriers to PCSK9 Therapies in ASCVD Treatment

Editorial 23 December, 2025

Recent discussions among healthcare experts have highlighted significant barriers that restrict the use of...

enlicitide-meets-all-endpoints-in-major-hypercholesterolemia-trial

Enlicitide Meets All Endpoints in Major Hypercholesterolemia Trial

Editorial 2 September, 2025

Merck has announced that its investigational oral PCSK9 inhibitor, enlicitide decanoate, has successfully met...